Direct-acting antivirals trigger a favorable, sustained virological response in patients with chronic hepatitis C infections and hepatocellular carcinoma

Podobne knjige/članki

• Predicting Hepatocellular Carcinoma Risk in Patients with Chronic HCV Infection and a Sustained Virological Response to Direct-Acting Antivirals
  od: D’Ambrosio, Roberta, et al.
  Izdano: (2021)
• Direct-Acting Antiviral Therapy and Risk of Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C
  od: Lee, Chang Hun, et al.
  Izdano: (2021)
• Direct-acting antivirals for patients with chronic hepatitis C and hepatocellular carcinoma in Taiwan
  od: Chen-Ta Chi, et al.
  Izdano: (2021-06-01)
• Sustained virological response by direct-acting antivirals reduces the recurrence risk of hepatitis C-related hepatocellular carcinoma after curative treatment
  od: Imai, Kenji, et al.
  Izdano: (2020)
• Incidence and Factors of Hepatocellular Carcinoma in Hepatitis C Virus Patients Achieving Sustained Virological Response After Direct-Acting Antiviral Treatment
  od: Juferdy Kurniawan Kurniawan, et al.
  Izdano: (2024-12-01)